Top Markets
#1 Akedo Akedo +114.63%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.38%
#4 Cross Cross +37.46%
#5 Black Phoenix Black Phoenix +34.01%
#6 Velvet Velvet +33.97%
#7 OVERTAKE OVERTAKE +18.40%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.68%
#9 QANplatform QANplatform +14.56%
#10 Illuvium Illuvium +12.98%
Coin of the day
Akedo Akedo
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc.

ASBP
Pozycja w akcjach #38720
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise... Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
Cena akcji
$7.28
Kapitalizacja rynkowa
$839.91K
Zmiana (1 dzień)
2.39%
Zmiana (1 rok)
-98.44%
Kraj
US
Handel Aspire Biopharma Holdings, Inc. (ASBP)

Kategoria

Healthcare
Historia ceny akcji dla Aspire Biopharma Holdings, Inc. (ASBP)
Najwyższa cena zamknięcia: $7.39 dnia 2026-08-01

Najniższa cena zamknięcia: $12.00K dnia 2022-04-01
Historia cen akcji firmy Aspire Biopharma Holdings, Inc. od 2022 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 27.39%
2025 -99.12%
2024 4.87%
2023 6.40%
2022 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.30 29.98%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $845.59 29.61%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE